2023-506345-34-00已完成1 期
An open-label, healthy subject, two-part study to assess the effect of verapamil on systemic exposure of EP395 (Part A), and to assess the effect of EP395 on systemic exposure of midazolam and digoxin (Part B)
Epiendo Pharmaceuticals ehf., Epiendo Pharmaceuticals ehf.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年9月26日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Kate Hanrott
Scientific
Epiendo Pharmaceuticals ehf.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A randomised, open-label, parallel group study to compare the pharmacokinetics and pharmacodynamics of NEODIDRO® 0.266 mg vs DIBASE® 25,000 IU oral doses in male and female patients.2024-516252-17-00Centro Ricerche Cliniche Di Verona S.r.l.48
进行中（未招募）
1 期
A 24-week, randomised, open-label, 2-arm study to compare the tolerability and efficacy of saquinavir tablets with ritonavir versus lopinavir/ritonavir tablets in HIV 1 infected adults switching from Kaletra capsules - LoCKIT StudyHuman Immunodeficiency Virus (HIV) Type-1 infectionMedDRA version: 8.1 Level: LLT Classification code 10020447 Term: Human immunodeficiency virus type I infection with other conditionsEUCTR2006-002585-19-GBRoyal Free Hampstead NHS Trust130
进行中（未招募）
不适用
An open-label, one-period, one-treatment study which objective is to evaluate the time course of the antiproteinuric and blood pressure lowering effect of renin inhibition with Aliskiren in patients with Type 2 diabetes suffering from incipient and/or established nephropathyHypertensionEUCTR2005-000361-19-DKovartis Pharma Services AG18
已完成
不适用
An open-label, single-dose, parallel-arm study to evaluate the pharmacokinetics and absolute bioavailability of GBR 830 following single dose administration by the subcutaneous (SC) routeautoimmune disease10003816NL-OMON42954Glenmark Pharmaceuticals SA40
已完成
4 期
Assessment of Zoledronic acid Utilizing Real-world Experience (AZURE)CTRI/2011/091/000046ovartis Healthcare Pvt Ltd3,400